News Website

Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers - Cancer Therapy Advisor

Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers Cancer Therapy Advisor

Published: March 17, 2024, 7 a.m.

Read Full Article

A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis - Nature.com

A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis Nature.com

Published: Feb. 12, 2024, 8 a.m.

Read Full Article

World Cancer Day 2024: 5 common cancers in women beyond cervical cancer - Hindustan Times

World Cancer Day 2024: 5 common cancers in women beyond cervical cancer Hindustan Times

Published: Feb. 4, 2024, 8 a.m.

Read Full Article

Gynecologic cancers: Early detection and understanding symptoms can save lives - University of Alabama at Birmingham

Gynecologic cancers: Early detection and understanding symptoms can save lives University of Alabama at Birmingham

Published: Jan. 26, 2024, 8 a.m.

Read Full Article

Latest Articles

Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers - Cancer Therapy Advisor

A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis - Nature.com

World Cancer Day 2024: 5 common cancers in women beyond cervical cancer - Hindustan Times

Gynecologic cancers: Early detection and understanding symptoms can save lives - University of Alabama at Birmingham

Subscribe to Our Newsletter